Akorn

Feb 11, 2021

Akorn Receives FDA Approval for Loteprednol Etabonate Ophthalmic Gel, 0.5%

Oct 28, 2020

Akorn Announces Its New Board of Directors

Oct 01, 2020

Akorn Successfully Completes Sale to Lenders and Exits Chapter 11 Protection

May 20, 2020

Akorn to Use Voluntary Chapter 11 Process to Position Business for Long-Term Success

Apr 01, 2020

Akorn Provides Update on Sale Process

Feb 10, 2020

Akorn Continues Negotiations with Lenders

Apr 09, 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline - AKRX

Apr 04, 2018

This Morning's Technical Outlook on Generic Drugs Stocks -- Lipocine, Akorn, Collegium Pharma, and Horizon Pharma

Feb 09, 2018

AKRX Investor Alert: Kyros Law is Filing Compensation Claims on Behalf of Akorn Pharmaceuticals (NASDAQ: AKRX) Investors

Feb 02, 2018

Quotidian Technical Highlights on Selected Generic Drugs Stocks -- Akorn, Collegium Pharma, Horizon Pharma, and Ironwood Pharma

Dec 13, 2017

This Morning's Technical Outlook on Generic Drugs Stocks -- Versartis, Akorn, Rigel Pharma, and Medicines

Nov 10, 2017

Breakfast Technical Briefing on Generic Drugs Stocks -- Mallinckrodt, Akorn, Pacira Pharma, and Rigel Pharma

Sep 26, 2017

Stocks Under Scanner in the Generic Drugs Space -- Akorn, Pacira Pharma, Rigel Pharma, and Lipocine

Jun 28, 2017

Generic Drugs Stocks on Investors' Radar -- Akorn, Collegium Pharma, Momenta Pharma, and Diplomat Pharma